United States – 02-14-2022 (PR Distribution™) –
Almost exactly one year ago today, an in-depth analysis and data-driven report of the impact COVID-19 will have on the erectile dysfunction market was published by Arizton Advisory & Intelligence. The report highlighted data which supports projections of the erectile dysfunction market in the U.S. to reach revenues of 4.7 billion dollars by 2026.
The report states that although the “market is likely to witness a negative growth rate of around (-0.4%) due to drastic decline in revenues of popular branded drugs such as Viagra and Cialis” that the “ED device market (primarily driven by shockwave therapy) is likely to grow at a faster rate and witness an absolute growth of around 22% during the forecast period.”
Technological advancements are paving the way for better and safer outcomes for men. One of the most promising technologies is low-intensity acoustic shockwave extracorporeal therapy (LI-ESWT) better known as GAINSWave®. “This therapy is already proven to be effective in cardiology, in the case of kidney stones, and observed recent success in reversible ischemic tissues of the heart and fractures. The LI-ESWT is a wand-like device placed near different areas of the penis, and it releases acoustic waves, which interact with the tissues and release angiogenic factors leading to improvement of blood circulation,” the report states.
In the 365 days following the data-analysis report, traffic to the GAINSWave website has increased by 104% and the brand has reached an all-time high of 2.11 million impressions in just the month of January, 2022 alone. Touted as the leader in the shockwave therapy market by the American Urological Association on September 10th, 2021, GAINSWave® shows no signs of slowing down, which is promising for their female inspired treatment, FemiWave®.
“I admire that GAINSWave has developed an anatomy-based protocol that actually works and doesn’t promise things to patients that just aren’t true,” shares Board-Certified Urologist, Dr. Bruce Sloane.” “Our goal with GAINSWave and FemiWave is to provide men and women with the educational and expert-driven information they need to find a qualified and sexual health physician for viable solutions,” shares GAINSWave CEO, Mark L. White.
To learn more about how doctors can offer GAINSWave to their patients, visit joingainswave.com. Men can learn more about GAINSWave Therapy or see which physicians in their communities offer treatment by visiting gainswave.com. Women interested in FemiWave can also visit https://femiwave.com
For the original news story, please visit https://www.prdistribution.com/news/over-2-11-million-men-have-conducted-internet-searches-in-january-2022-alone-to-learn-about-gainswave-therapy-for-erectile-dysfunction-2.html.